| Metric | Q3 2026 | Q3 2025 |
|---|---|---|
| Revenue | 1,358.3 | 993.7 |
| Profit before tax | -8.1 | 3.7 |
| Net income | -8.1 | 3.7 |
| EPS (diluted, $ a share) | $-0.04 | $0.02 |
A dash means the filing did not report that period. Growth is not shown when either period was a loss. Figures from the filing's XBRL data.
| Revenue, year on year | +36.7% |
|---|---|
| Operating margin | -0.3% |
10-Q filed with the SEC, NASDAQ: ALHC. Figures from the filing's XBRL data; summary written with AI assistance from the filing.
Alignment Healthcare, Inc.: key numbers
- Share price
- $7.62Close, Nov 17
- Market cap
- $1.59B
- Shares outstanding
- 209.27MLatest SEC cover page
- Sector
- Finance
- Industry
- Hospital & Medical Service PlansSIC 6324
Today's reference numbers, updated daily. Not a valuation or a recommendation.
More from Alignment Healthcare, Inc.
All →Alignment Healthcare EVP, Corporate Affairs Joseph S. Konowiecki Sells $35.5K of Stock
Joseph S. Konowiecki, EVP, Corporate Affairs, sold 4,930 shares of Alignment Healthcare, Inc. at $7.20 a share, worth $35.5K in total on Nov 10, 2026. Shares held after the trade: 1,075,375 (-0.5%).
- Value
- $35.5K
- Shares
- 4,930
- Price
- $7.20
- Role
- EVP, Corporate Affairs
- Holding change
- -0.5%
- Trade date
- Nov 10, 2026
Alignment Healthcare Financial Results
Alignment Healthcare reported Q3 2026 revenue of $1.36 billion, a 36.7% year-over-year increase, driven by a 31.2% growth in health plan membership to 301,200 members. Despite the revenue growth, the company lowered its full-year 2026 adjusted gross profit and adjusted EBITDA guidance due to higher-than-expected medical trends and costs in catastrophic cases and skilled nursing.
- Term
- Q3 2026
“Our third-quarter membership and revenue growth demonstrate continued demand for Alignment’s products and services, while medical trends ran higher than expected. We are taking a prudent approach to the fourth quarter and lowering our outlook based on current headwinds.”
John Kao, chairman and CEO
Alignment Healthcare Business Update
Alignment Healthcare announced that its primary California HMO health plan (H3815), which serves 75% of its membership, received a 3.5-Star Rating from CMS for 2027, down from 4.0 Stars in 2026. The company intends to appeal the calculations and pursue litigation regarding the methodologies used, noting that the rating change will impact quality bonus payments in fiscal year 2028 but not revenue in 2026 or 2027.
- Counterparty
- Centers for Medicare & Medicaid Services (CMS)
- Term
- Rating Year 2027
Alignment Healthcare CMO Hyong Kim Sells $270K of Stock
Hyong Kim, CMO, sold 32,479 shares of Alignment Healthcare, Inc. at $8.30 a share, worth $270K in total on Oct 6, 2026. Shares held after the trade: 299,271 (-9.8%).
- Value
- $270K
- Shares
- 32,479
- Price
- $8.30
- Role
- CMO
- Holding change
- -9.8%
- Trade date
- Oct 6, 2026
Alignment Healthcare EVP, Corporate Affairs Joseph S. Konowiecki Sells $202K of Stock
Joseph S. Konowiecki, EVP, Corporate Affairs, sold 23,511 shares of Alignment Healthcare, Inc. at $8.61 a share, worth $202K in total on Sep 17, 2026. Shares held after the trade: 1,080,305 (-2.1%).
- Value
- $202K
- Shares
- 23,511
- Price
- $8.61
- Role
- EVP, Corporate Affairs
- Holding change
- -2.1%
- Trade date
- Sep 17, 2026
Alignment Healthcare CEO John E. Kao Sells $356K of Stock
John E. Kao, CEO, sold 27,400 shares of Alignment Healthcare, Inc. at $13.00 a share, worth $356K in total on Sep 14, 2026. Shares held after the trade: 590,766 (-4.4%).
- Value
- $356K
- Shares
- 27,400
- Price
- $13.00
- Role
- CEO
- Holding change
- -4.4%
- Trade date
- Sep 14, 2026